Cargando…

Effect of Hyaluronic Acid and Pluronic-F68 on the Surface Properties of Foam as a Delivery System for Polidocanol in Sclerotherapy

The use of foams to deliver bioactive agents and drugs is increasing in pharmaceutics. One example is the use of foam as a delivery system for polidocanol (POL) in sclerotherapy, with the addition of bioactive compounds to improve the delivery system being a current subject of study. This work shows...

Descripción completa

Detalles Bibliográficos
Autores principales:	del Castillo-Santaella, Teresa, Yang, Yan, Martínez-González, Inmaculada, Gálvez-Ruiz, María José, Cabrerizo-Vílchez, Miguel Ángel, Holgado-Terriza, Juan Antonio, Selles-Galiana, Fernando, Maldonado-Valderrama, Julia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693533/ https://www.ncbi.nlm.nih.gov/pubmed/33143001 http://dx.doi.org/10.3390/pharmaceutics12111039

Ejemplares similares

Sclerotherapy using polidocanol foam for a giant splenic cyst
por: Funakoshi, Hiraku, et al.
Publicado: (2020)

Foam Polidocanol Sclerotherapy for Low-Flow Vascular Malformations of Tongue
por: Mukul, Sailesh Kumar, et al.
Publicado: (2019)

Sclerotherapy with 3% polidocanol foam: revolutionizing outpatient treatment in patients with haemorrhoidal disease
por: Gallo, Gaetano, et al.
Publicado: (2021)

Bilateral foam polidocanol sclerotherapy of great saphenous veins and their tributaries in synchronous procedure
por: Miranda, Luiz Antonio, et al.
Publicado: (2021)

Ethanol sclerotherapy or polidocanol sclerotherapy for symptomatic hepatic cysts
por: Wijnands, Titus FM, et al.
Publicado: (2018)

Digital Subtraction Angiography-Guided Foam Sclerotherapy with Polidocanol for Treating Superficial Venous Malformation
por: Anh, Tuan Tran, et al.
Publicado: (2021)

Sclerotherapy on Demand with Polidocanol to Treat HHT Nosebleeds
por: Marcos, Sol, et al.
Publicado: (2021)

Therapeutic Effect of Polidocanol Sclerotherapy on Oral Vascular Malformations
por: Fukuzawa, Satoshi, et al.
Publicado: (2021)

Ultrasound-guided foam sclerotherapy of great saphenous vein with 2% polidocanol – one-year follow-up results
por: Kurnicki, Jacek, et al.
Publicado: (2016)

Polidocanol foam sclerotherapy in the treatment of hemorrhoidal disease in patients with bleeding disorders: a multicenter, prospective, cohort study
por: Salgueiro, P., et al.
Publicado: (2022)

Familial Disseminated Cutaneous Glomuvenous Malformation: Treatment with Polidocanol Sclerotherapy
por: Jha, Aditi, et al.
Publicado: (2016)

Successful Endoscopic Sclerotherapy Using Polidocanol for Small Bowel Hemangioma
por: Aoyama, Taiki, et al.
Publicado: (2020)

Polidocanol sclerotherapy for multiple gastrointestinal hemangiomas: A case report
por: Yao, Huan, et al.
Publicado: (2021)

Sclerotherapy with polidocanol microfoam in head and neck venous and lymphatic malformations
por: De Corso, Eugenio, et al.
Publicado: (2021)

Successful Treatment of Acquired Vulvar Lymphangiectasia with 1% Polidocanol Sclerotherapy
por: STULL, Carolyn M., et al.
Publicado: (2021)

3% Polidocanol Sclerotherapy for Pyogenic Granuloma: Efficacy and Safety Analysis
por: Deshpande, Ajay J, et al.
Publicado: (2022)

Influence of polidocanol ultrasound-guided foam sclerotherapy on quality of life in lower extremity chronic venous disease: initial results
por: Polimanti, Afonso César, et al.
Publicado: (2019)

Sclerotherapy with 3% polidocanol foam for third- and fourth-degree hemorrhoids as “bridge treatment” during the COVID-19 pandemic in Italy
por: Lisi, Giorgio, et al.
Publicado: (2021)

Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes
por: Pata, Francesco, et al.
Publicado: (2021)

Transcervical administration of polidocanol foam prevents pregnancy in female baboons()()
por: Jensen, Jeffrey T., et al.
Publicado: (2016)

Sclerotherapy with polidocanol for treatment of aneurysmal bone cysts: Good results in 37 of 38 consecutive patients
por: Brosjö, Otte, et al.
Publicado: (2013)

Polidocanol Sclerotherapy Combined with Transarterial Embolization Using n-Butyl Cyanoacrylate for Extracranial Arteriovenous Malformations
por: Kitagawa, Akira, et al.
Publicado: (2018)

A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM)
por: Gallo, G., et al.
Publicado: (2022)

Efficacy and Safety of Ultrasound-Guided Percutaneous Polidocanol Sclerotherapy in Benign Cystic Thyroid Nodules: Preliminary Results
por: Gong, Xiaohua, et al.
Publicado: (2017)

A Rare Case of Aneurysmal Bone Cyst – Navicular Bone Treated by Intralesional Sclerotherapy Agent Polidocanol
por: Bansal, Kapil, et al.
Publicado: (2021)

Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams
por: Carugo, Dario, et al.
Publicado: (2015)

Effect of Multiple Factors on Foam Stability in Foam Sclerotherapy
por: Bai, Taoping, et al.
Publicado: (2018)

Comparison between the use of 99% ethanol and 3% polidocanol in percutaneous echoguided sclerotherapy treatment of simple renal cysts
por: Dell’Atti, Lucio
Publicado: (2015)

Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial
por: Bertanha, Matheus, et al.
Publicado: (2014)

Brushite foams—the effect of Tween® 80 and Pluronic® F‐127 on foam porosity and mechanical properties
por: Unosson, Johanna, et al.
Publicado: (2016)

Cerebrovascular ischemia following ultrasound-guided foam sclerotherapy
por: Bittencourt, Agamenon Hülse, et al.
Publicado: (2018)

Foam Sclerotherapy for Conjunctival Inclusion Cyst Post Evisceration
por: Thomas, Rwituja, et al.
Publicado: (2023)

Development of Glycerol-Rose Bengal-Polidocanol (GRP) foam for enhanced sclerosis of a cyst for cystic diseases
por: Jeong, Soohyun, et al.
Publicado: (2021)

"Hidrocele: Tratamiento con Polidocanol". /
por: Mijangos Carpenti, Martín Gabriel
Publicado: (1995)

Foam Sclerotherapy during Shunt Surgery for Portal Hypertension and Varices
por: Zhang, Zhe, et al.
Publicado: (2017)

Usefulness of antegrade foam sclerotherapy for portal hypertensive variceal bleeding
por: Park, Go Woon, et al.
Publicado: (2023)

Percutaneous sclerotherapy with polidocanol under the guidance of ultrasound for venous malformations in children – A retrospective cohort study from a single tertiary medical center
por: Hou, Fang, et al.
Publicado: (2020)

Comment on Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218
por: Jongen, Johannes, et al.
Publicado: (2022)

Correction: Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218
por: Pata, Francesco, et al.
Publicado: (2023)

Autotitrator based on an Arduino Open Source Pump
por: del Castillo-Santaella, Teresa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5agl9u6i9av9dvaak8mcmsu5gd